-- Apogee, BioSante, FedEx, Michael Kors, SonoSite, WebMD: U.S. Equity Movers
-- B y   K s e n i a   G a l o u c h k o
-- 2011-12-15T21:25:48Z
-- http://www.bloomberg.com/news/2011-12-14/aetna-antares-biosante-pharmaceuticals-nordson-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in New York.  Apogee Enterprises Inc. (APOG)   rose 16 percent to
$12.25, the intraday price since July 22. The maker of glass
products reported third-quarter revenue of $174.9 million,
compared with the average analyst estimate of $171 million.  BioSante Pharmaceuticals Inc. (BPAX)   plunged 77 percent
to 48 cents, the biggest drop since at least September 1999. The
developer of hormone-replacement products’ LibiGel, an
experimental compound intended to boost women’s libido, failed
to work in two large studies.  Antares Pharma Inc. (AIS)  ,
which is developing the pharmaceutical delivery system for
LibiGel, retreated 30 percent to $1.67.  Bonanza Creek Energy Inc.  (BCEI US) declined 20 percent to
$13.61 on the first day of trading. The Denver-based oil and
natural gas company sold 10 million shares at $17 a share, below
the planned range of $20 to $22 a share.  Deckers Outdoor Corp. (DECK)   had the biggest decline in
the Russell 1000 Index, erasing 9.6 percent to $86.46. The maker
of Ugg boots and Teva sandals was cut to “underperform” from
“buy” by Sterne Agee & Leach Inc.  FedEx Corp. (FDX)   advanced 8 percent, the most since
April 2009, to $83.47. The operator of the world’s biggest cargo
airline reported second-quarter profit of $1.57 a share, beating
the average analyst estimate of $1.53.  First Solar Inc. (FSLR)   declined 6 percent to $31.45,
the biggest decline in the  S&P 500 . The world’s largest maker of
thin-film solar panels was downgraded to “neutral” from
“outperform” at Robert W. Baird & Co., which cited the
“negative impact” of the company’s effort to transform itself
from a technology to an energy company.  Imperial Sugar Co. (IPSU)   tumbled 24 percent to $3.31,
the lowest intraday price since December 2002. The  Sugar Land ,
Texas-based company said it expects to include concern about
staying in business in its financial statement for the year
ended Sept. 30. The company canceled a conference call with
investors scheduled today.  Michael Kors Holdings Ltd.  (KORS US) rallied 21 percent to
$24.27 on the first day of trading. The clothing company founded
by the designer of that name raised $944 million in an initial
public offering, 19 percent more than it sought, after pricing
its shares above the marketed range.  Nordson Corp. (NDSN)   fell 9.2 percent, the most since
Aug. 8, to $40.43. The maker of adhesive equipment said first-
quarter earnings excluding some items will be no more than 61
cents a share, below the average analyst estimate of 67 cents a
share.  Novellus Systems Inc. (NVLS)   rallied 16 percent to
$40.37 for the biggest advance in the S&P 500. The maker of
machinery used in semiconductor production was acquired by  Lam
Research Corp. (LRCX)   for about $3.3 billion in stock,
combining two of the chip-equipment industry’s biggest companies
in a challenge to market leader  Applied Materials Inc. (AMAT)  . Lam Research fell 8.4 percent to $36.17.  SonoSite Inc. (SONO)   surged 27 percent to $53.70, the
highest price since 1998. The ultrasound-equipment maker agreed
to be acquired by Fujifilm Holdings Corp. (FUJIY US) for about
$995 million, or $54 a share, including debt owed to
noteholders.  WebMD Health Corp. (WBMD)   rose 9.1 percent to $37.75,
the highest price since July 15. The medical-information company
is being targeted by four buyout firms, including KKR & Co. and
Providence Equity Partners LP, the  New York  Post reported,
citing unidentified people with knowledge of the matter. A
spokeswoman for WebMD didn’t return calls requesting comment,
the newspaper said.  To contact the reporter on this story:
Ksenia Galouchko in New York at 
 kgalouchko1@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 